SC

Sheatree Capital

North America, New York, United States, Florida

Description

Sheatree Capital operates an investment firm.

Investor Profile

Sheatree Capital has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series B (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Pharmaceutical
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sheatree Capital frequently co-invest with?

Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Playground Global
North America, California, United States, Palo Alto
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Qatar Investment Authority
Asia, Ad Dawhah, Qatar, Doha
Co-Investments: 1
Breton Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 1
Abstract Ventures
North America, California, United States, San Francisco
Co-Investments: 1
BO
North America, New York, United States, New York
Co-Investments: 1
Mubadala Capital
Asia, Dubai, United Arab Emirates, Dubai
Co-Investments: 1

Which angels does Sheatree Capital often collaborate with?

RS
North America, Washington, United States, Seattle
Shared Deals: 1

What are some of recent deals done by Sheatree Capital?

Link Cell Therapies

San Francisco, California, United States

Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.

BiotechnologyLife ScienceMedical
Series ADec 15, 2025
Amount Raised: $60,000,000
Outpace Bio

Seattle, Washington, United States

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

BiotechnologyHealth CareLife SciencePharmaceutical
Series BAug 1, 2024
Amount Raised: $144,000,000
RareCyte

Seattle, Washington, United States

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series UnknownJun 27, 2024
Amount Raised: $20,000,000

Find More Investors Like Sheatree Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides